Chilean quits company boards to fight U.S. insider trading charges

SANTIAGO, Dec 23 (Reuters) - A Chilean businessman charged by U.S. regulators with insider trading linked to Abbot Laboratories $2.9 billion acquisition of a pharmaceutical firm said on Tuesday he had quit several board positions to defend his case.